Integrating Genetic and Genomic Testing Into Oncology Practice.

Area of Science:

• Oncology
• Medical Genetics

Background:

• Germline and somatic genetic information are increasingly crucial in cancer management.
• Germline mutations can identify individuals at high risk for hereditary cancers, informing screening and prevention.
• Genetic mutations in cancer patients influence both local and systemic treatment strategies.

Purpose of the Study:

• To review the role of germline and somatic genetic information in cancer therapeutic decision-making.
• To discuss the application of genetic findings in cancer prevention and management across selected cancer types.

Main Methods:

• Review of current literature and clinical guidelines.
• Analysis of genetic data in the context of therapeutic strategies for various cancers.

Main Results:

• Germline mutations can predict cancer risk and guide preventative measures.
• Somatic mutations are key in selecting targeted therapies and optimizing cancer treatment.
• Genetic insights personalize cancer care, improving outcomes.

Conclusions:

• Integrating germline and somatic genetic information is essential for comprehensive cancer management.
• Genetic testing offers significant benefits for both cancer prevention and treatment personalization.
• Further research is needed to fully leverage genetic data in oncology.